Fatima Ahmad, PharmD is Vice President of Medical Affairs at Castle Creek Biosciences, a clinical-stage cell and gene therapy company focused on developing and commercializing disease-modifying therapies for patients suffering from rare diseases for which there is a lack of available treatment options.  Previously, she held positions at Spark Therapeutics, a member of the Roche group, including heading the Medical Communications team responsible for leading integrated Medical Communications Strategies across therapeutic areas in Spark’s portfolio of AAV-based investigational gene therapies, as well as serving as Therapeutic Area Leader for hematology. Previously, Fatima spent time at Advaxis Immunotherapies as Senior Director Medical Affairs and at Otsuka Pharmaceuticals, where she held roles of increasing seniority in US and Global Medical Affairs.

Fatima began her industry career at AstraZeneca where she was a Pharmacy intern and subsequently held roles in Medical Information and Medical Communication Science, working across several therapeutic areas including respiratory and oncology. She graduated Magna Cum Laude from Temple University with a PharmD degree, and practiced community pharmacy briefly before transitioning to the pharmaceutical industry. Fatima is passionate about incorporating a patient-centric approach to all aspects of Medical Affairs and is committed to the evolution of Medical Affairs in best serving patients in the era of personalized medicine and novel therapeutic modalities.